Elevated levels of two major Wnt signaling inhibitors, such as DKK1 and sclerostin, have been found in serum from MM patients, correlating with the presence of focal bone lesions or the extent of bone disease [129,130]. Here, DKK1 is linked to Miyoshi myopathy.